Smith & Nephew (SNN) Total Current Liabilities (2009 - 2025)
Smith & Nephew (SNN) reported Total Current Liabilities of $1.6 billion for Q4 2025, up 4.18% on a YoY basis from $1.5 billion in Q4 2024, and up 4.18% quarter-over-quarter from $1.5 billion in Q4 2024.
Smith & Nephew (SNN) Total Current Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Total Current Liabilities for 17 years, with the latest figure at $1.6 billion in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 4.18% year-over-year to $1.6 billion; the trailing twelve-month figure through Dec 2025 stood at $1.6 billion (up 4.18% YoY), and the FY2025 full-year result was $1.6 billion, up 4.18% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $1.6 billion, up from $1.5 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $2.3 billion in Q4 2023, with the low at $1.5 billion in Q4 2024.
- Historically, Total Current Liabilities has averaged $1.8 billion across 5 years, with a median of $1.7 billion in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 32.42% — and 2024, when it slumped 32.58%.
- Smith & Nephew's Total Current Liabilities stood at $2.1 billion in 2021, then slipped by 19.52% to $1.7 billion in 2022, then jumped by 32.42% to $2.3 billion in 2023, then plunged by 32.58% to $1.5 billion in 2024, then grew by 4.18% to $1.6 billion in 2025.
- The last three Total Current Liabilities figures came in at $1.6 billion (Q4 2025), $1.5 billion (Q4 2024), and $2.3 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | 1.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.53 Bn |
| Dec 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Dec 31, 2021 | 2.13 Bn |
| Dec 31, 2020 | 1.69 Bn |
| Dec 31, 2019 | 1.56 Bn |
| Dec 31, 2018 | 1.47 Bn |
| Dec 31, 2017 | 1.35 Bn |
| Dec 31, 2016 | 1.35 Bn |
| Dec 31, 2015 | 1.34 Bn |
| Jun 30, 2015 | 1.23 Bn |
| Dec 31, 2014 | 1.16 Bn |
| Jun 28, 2014 | 1.15 Bn |
| Mar 31, 2014 | 1.06 Bn |
| Dec 31, 2013 | 1.07 Bn |
| Sep 28, 2013 | 3.40 Bn |
| Mar 31, 2013 | 916.00 Mn |
| Dec 31, 2012 | 930.00 Mn |
| Sep 29, 2012 | 908.00 Mn |